Use of biomarkers in the context of orphan medicines designation in the European Union.
Tsigkos S, Llinares J, Mariz S, Aarum S, Fregonese L, Dembowska-Baginska B, Elbers R, Evers P, Foltanova T, Lhoir A, Corrêa-Nunes A, O'Connor D, Voordouw A, Westermark K, Sepodes B.
Tsigkos S, et al.
Orphanet J Rare Dis. 2014 Jan 27;9:13. doi: 10.1186/1750-1172-9-13.
Orphanet J Rare Dis. 2014.
PMID: 24461084
Free PMC article.